Author

C. Costechareyre

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Assay:bulk RNA-seq· 2 Organism:chicken / avian· 2 Research Focus:drug response / drug discovery· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Organism:zebrafish· 1

Frequent Co-Authors

L. Jarrosson· 3 shared V. Castellani· 3 shared C. Delloye-Bourgeois· 2 shared M. Lacourrege· 2 shared R. Teinturier· 2 shared A. Eberhardt· 1 shared A. T. Glehen· 1 shared A. Verney· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

L. Jarrosson

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Functional precision oncology for follicular lymphoma with patient-derived xenograft in avian embryos

M. Zala, B. Lipinski, C. Costechareyre, L. Jarrosson, R. Teinturier, E. Julia, M. Lacourrege, A. Verney, J. Guitton, A. T. Glehen, E. Bachy, G. Salles, S. Huet, L. Genestier, V. Castellani, , P. Sujobert

This study develops a xenograft model in avian embryos to study follicular lymphoma response to RCHOP therapy, identifying a gene signature and validating BAX as a key effector of treatment.

bioRxiv · Jun 22, 2023 · PreprintCancer Biology

An in vivo avian model of human melanoma to perform rapid and robust preclinical studies

L. Jarrosson, S. Dalle, C. Costechareyre, Y. Tang, M. Grimont, M. Plaschka, M. Lacourrege, R. Teinturier, M. Le Bouar, D. Maucort-Boulch, A. Eberhardt, V. Castellani, J. Caramel, C. Delloye-Bourgeois

This paper develops an avian xenograft model to rapidly study melanoma drug responses and resistance mechanisms in vivo.

bioRxiv · Oct 12, 2022 · PreprintCancer Biology

Modeling breast cancer by grafting patient tumor samples in the avian embryo: an in vivo platform for therapy evaluation coupled to large scale molecular analyses

L. Jarrosson, C. Costechareyre, F. Gallix, S. Cire, F. Gay, O. Imbaud, E. Marangoni, K. Aguera, C. Delloye-Bourgeois, V. Castellani

The paper develops an in vivo model using avian embryos to study triple negative breast cancer and evaluate therapies through molecular analysis.

bioRxiv · Apr 26, 2021 · PreprintCancer Biology